Daehan Nupharm Co.,Ltd. (KOSDAQ:054670)
South Korea · Delayed Price · Currency is KRW 5,730.00
+100.00 (1.78%)
At close: Jul 10, 2026
Daehan Nupharm Market Cap
Daehan Nupharm has a market cap or net worth of 80.42 billion as of July 10, 2026. Its market cap has decreased by -27.83% in one year.
Market Cap
80.42B
Enterprise Value
154.59B
Revenue
205.39B
Ranking
n/a
PE Ratio
5.13
Stock Price
5,730.00
Market Cap Chart
Since March 3, 2003, Daehan Nupharm's market cap has increased from 13.03B to 80.42B, an increase of 517.11%. That is a compound annual growth rate of 8.10%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 10, 2026 | 80.42B | -12.79% |
| Dec 30, 2025 | 92.21B | -4.37% |
| Dec 30, 2024 | 96.42B | -24.09% |
| Dec 28, 2023 | 127.02B | 5.97% |
| Dec 29, 2022 | 119.86B | -21.65% |
| Dec 30, 2021 | 152.98B | -13.49% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| DongKoo Bio & Pharma | 101.00B |
| H.PIO | 90.60B |
| WITHUS PHARMACEUTICAL Co.,LTD. | 87.12B |
| KOREA PHARMA | 84.85B |
| Sam-A Pharm. | 78.24B |
| Hwail Pharmaceutical | 71.89B |
| Polaris AI Pharma | 71.73B |
| Optipharm.CO.,LTD | 69.02B |